Table 2.
Clinical Outcomes | Effect Comparison (95% CI)* | P |
---|---|---|
Mortality (PICU discharge): HR† | 1.78 (.53–6.05) | .35 |
First intervention (outcome = OI)‡ | ||
Treatment × time interaction | — | .64 |
Second intervention (outcome = OI)‡ | ||
Treatment × time interaction | — | .52 |
Deterioration in POPC score: OR† | .57 (.11–2.85) | .49 |
Deterioration in PCPC score: OR† | .45 (.09–2.22) | .33 |
Retreated (received the second intervention): OR† | .44 (.08–2.35) | .34 |
Expected no. of VFDs: RR† | 1.11 (.88–1.41) | .37 |
Unsuccessful extubation§: OR† | .58 (.12–2.77) | .50 |
HR indicates hazard ratio; OR, odds ratio; RR, rate ratio.
All effects compare the calfactant group with the placebo group.
Adjusted for risk strata + PRISM score.
Adjusted for risk strata.
Defined as free from mechanical ventilation for greater than 48 hours.